Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dapsone-Induced Hypersensitivity Pneumonitis in Borderline Tuberculoid Leprosy.

International journal of dermatology·2025
Same author

Automated posture adjustment system for immobilized patients using EEG signals.

Computer methods in biomechanics and biomedical engineering·2025
Same author

Morphometric study of proximal tubular cell mitochondria using TEM images in renal diseases.

Ultrastructural pathology·2025
Same author

Glomerulitis in T cell-mediated renal allograft rejection and antibody-mediated rejection histology in the absence of donor-specific antibodies heralds a similar clinico-morphologic pattern of injury to an antibody-mediated rejection: A systematic review.

Medical journal, Armed Forces India·2025
Same author

ML3CNet: Non-local means-assisted automatic framework for lung cancer subtypes classification using histopathological images.

Computer methods and programs in biomedicine·2024
Same author

Tunable <i>Q</i>-factor wavelet transform based identification of diabetic patients using ECG signals.

Computer methods in biomechanics and biomedical engineering·2024
Same journal

Multimodal Contrastive Spatiotemporal Self-Organizing Neural Networks for In-Home Activity Learning of Mild Cognitive Impairment.

IEEE journal of biomedical and health informatics·2026
Same journal

Integrating Multi-View Residue Graph and Protein Language Model for Cell-Penetrating Peptide Prediction via Global-Local Graph Aggregation and Cross-Attentive Fusion.

IEEE journal of biomedical and health informatics·2026
Same journal

An Ultra-Lightweight Cross-scale Attention Mamba Network for Accurate Skin Lesion Segmentation.

IEEE journal of biomedical and health informatics·2026
Same journal

Explanation-Guided Reconstruction of Missing Clinical Features for Survival Prediction in Pancreatic Cancer.

IEEE journal of biomedical and health informatics·2026
Same journal

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same journal

Patient-specific Biomechanical Investigation of Percutaneous Pulmonary Valves: Towards the Integration of Routinely Acquired Clinical Data and Fluid-structure Interaction Simulations.

IEEE journal of biomedical and health informatics·2026
See all related articles

Related Experiment Video

Updated: May 9, 2026

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.1K

NeuroFormer: A Deep Learning Framework for Alzheimer's Detection Using EEG Signals.

Rajveer Singh Lalawat, Nikhil Kushwaha, Varun Bajaj

    IEEE Journal of Biomedical and Health Informatics
    |August 22, 2025
    PubMed
    Summary
    This summary is machine-generated.

    A new deep learning model, NeuroFormer, accurately classifies Alzheimer's disease (AD) and Frontotemporal dementia (FTD) using EEG signals. This technology offers a promising tool for early dementia diagnosis.

    More Related Videos

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    17.5K
    Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.3K

    Related Experiment Videos

    Last Updated: May 9, 2026

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
    09:38

    Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

    Published on: November 14, 2017

    15.1K
    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
    12:28

    Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

    Published on: June 3, 2020

    17.5K
    Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
    09:47

    Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

    Published on: December 15, 2023

    1.3K

    Area of Science:

    • Neuroscience
    • Artificial Intelligence
    • Medical Diagnostics

    Background:

    • Alzheimer's disease (AD) and Frontotemporal dementia (FTD) are neurodegenerative disorders with overlapping symptoms, complicating diagnosis.
    • Accurate and timely diagnosis is critical for effective dementia treatment and intervention planning.
    • Current diagnostic methods face challenges due to symptom heterogeneity and complex pathological mechanisms.

    Purpose of the Study:

    • To develop a novel deep learning architecture, NeuroFormer, for classifying EEG signals.
    • To differentiate between Alzheimer's disease (AD), Frontotemporal dementia (FTD), and healthy controls (CN) using non-invasive neurophysiological measurements.
    • To establish a robust diagnostic framework for early dementia detection.

    Main Methods:

    • Proposed NeuroFormer, a deep learning model integrating spectral processing, neural dynamics, capsule routing, and attention mechanisms.
    • Utilized EEG signals captured via non-invasive neurophysiological instruments.
    • Employed dynamic spectral gating, graph convolutions, and multi-scale adaptive feature pyramids for spatiotemporal feature extraction.

    Main Results:

    • NeuroFormer achieved a classification accuracy of 95.76% for AD, FTD, and CN.
    • The model significantly outperformed benchmark models across all key evaluation metrics.
    • Demonstrated effective extraction of discriminative spatiotemporal features from raw EEG data.

    Conclusions:

    • NeuroFormer shows significant potential as a measurement-driven diagnostic framework for dementia.
    • The model enables early and accurate classification of dementia-related disorders using EEG instrumentation.
    • This approach offers a non-invasive method for distinguishing between AD, FTD, and healthy individuals.